share_log

Eli Lilly and Co | DEFA14A: Others

Eli Lilly and Co | DEFA14A: Others

礼来 | DEFA14A:其他
SEC announcement ·  03/22 16:29
Moomoo AI 已提取核心信息
Eli Lilly and Co has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its proxy statement. This filing, known as a Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by Eli Lilly and Co, the registrant, indicating that no third party was involved in the filing process. Furthermore, the company has confirmed that no filing fee was required for this submission. The definitive additional materials are part of the company's ongoing communication with its shareholders and the SEC.
Eli Lilly and Co has filed definitive additional materials with the United States Securities and Exchange Commission (SEC) as part of its proxy statement. This filing, known as a Schedule 14A, is a requirement under Section 14(a) of the Securities Exchange Act of 1934. The materials were filed by Eli Lilly and Co, the registrant, indicating that no third party was involved in the filing process. Furthermore, the company has confirmed that no filing fee was required for this submission. The definitive additional materials are part of the company's ongoing communication with its shareholders and the SEC.
作为委托书的一部分,礼来公司已向美国证券交易委员会(SEC)提交了明确的补充材料。这份文件被称为附表14A,是1934年《证券交易法》第14(a)条的要求。这些材料是由注册人礼来公司提交的,表明没有第三方参与申报流程。此外,该公司已确认本次提交不需要任何申请费。最终的额外材料是公司与股东和美国证券交易委员会持续沟通的一部分。
作为委托书的一部分,礼来公司已向美国证券交易委员会(SEC)提交了明确的补充材料。这份文件被称为附表14A,是1934年《证券交易法》第14(a)条的要求。这些材料是由注册人礼来公司提交的,表明没有第三方参与申报流程。此外,该公司已确认本次提交不需要任何申请费。最终的额外材料是公司与股东和美国证券交易委员会持续沟通的一部分。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息